Envista Holdings Corp
NYSE:NVST
Envista Holdings Corp
Operating Income
Envista Holdings Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
E
|
Envista Holdings Corp
NYSE:NVST
|
Operating Income
$324.9m
|
CAGR 3-Years
28%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Envista Holdings Corp's Operating Income?
Operating Income
324.9m
USD
Based on the financial report for Dec 31, 2023, Envista Holdings Corp's Operating Income amounts to 324.9m USD.
What is Envista Holdings Corp's Operating Income growth rate?
Operating Income CAGR 5Y
2%
Over the last year, the Operating Income growth was -10%. The average annual Operating Income growth rates for Envista Holdings Corp have been 28% over the past three years , 2% over the past five years .